Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Equities
  • Large Cap
  • Markets
  • News

Confluent’s Revised Revenue Projections And Gross Margin Outlook Prompt Analyst Downgrade

By Lekha Gupta
June 15, 2:43 PM
Guggenheim Securities analyst Howard Ma downgraded Confluent Inc (NASDAQ: CFLT) to Neutral from Buy and 

CFLT

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

AbbVie Touts Promising Results For Risankizumab For Ulcerative Colitis Maintenance

By Vandana Singh
June 15, 11:39 AM
AbbVie Inc (NYSE: ABBV) announced top-line results from the COMMAND Phase 3 maintenance study, showing risankizumab (Skyrizi) achieved the primary endpoint of clinical remission at week 52, as well as key secondary endpoints in moderately to 

ABBV

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • Movers
  • News
  • Small Cap

AbbVie vs Coherus: Dispute Emerges over Upcoming Launch of Low-Cost Biosimilar, Yusimry

By Vandana Singh
June 15, 11:24 AM
AbbVie Inc (NYSE: ABBV) has challenged Coherus BioSciences Inc (NASDAQ: CHRS), alleging Coherus breached its settlement and license agreement after it announced its plans to launch Yusimry, a biosimilar of

ABBV

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • Movers
  • News
  • Trading Ideas

AbbVie Says BeiGene’s Flagship Blood Cancer Drug Infringes Imbruvica Patent

By Vandana Singh
June 15, 11:20 AM
BeiGene Ltd (NASDAQ: BGNE) says it is aware that Pharmacyclics LLC has filed a complaint alleging that BeiGene's blood cancer therapy Brukinsa (zanubrutinib) infringes a Pharmacyclics 

ABBV

Read More
1 minute read
  • Dividends
  • Equities
  • Large Cap
  • Markets
  • News

Delta Air Lines Resumes Dividend Payment After Three Year Suspension

By Lekha Gupta
June 15, 11:08 AM
Delta Air Lines Inc (NYSE: DAL) reported the resumption of dividend payments after suspending them in March 2020 

DAL

Read More
1 minute read
  • Equities
  • Government
  • Large Cap
  • M&A
  • Markets
  • Media
  • Penny Stocks
  • Regulations

Vodafone-CK Hutchison’s UK Merger Under CMA Scrutiny: Report

By Lekha Gupta
June 15, 7:56 AM
The merger of Vodafone Group PLC (NASDAQ: VOD) and CK Hutchison Holdings Ltd (OTC: CKHUY) (OTC: CKHUF) UK telecommunication business

ATVI

Read More
1 minute read
  • Buybacks
  • Equities
  • Large Cap
  • Markets
  • News

AutoZone Bumps Up Share Buyback Authorization By $2B

By Lekha Gupta
June 15, 5:51 AM
AutoZone Inc (NYSE: AZO) disclosed the share buyback authorization of an additional $2.0 billion shares related to its

AZO

Read More
2 minute read
  • Asia
  • General
  • Global
  • Large Cap
  • Markets
  • Mid Cap
  • News
  • Topics
  • Trading Ideas

Warren Buffett’s Bets On This Country Tripled To $17 Billion: Hint, It’s Not The US

By AJ Fabino
June 14, 5:44 PM
Warren Buffett consistently demonstrates a knack for spotting undervalued companies and making calculated, often surprising moves. One of…

BRK-A

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Initiation
  • Large Cap
  • Markets

ServiceNow’s Subscription Revenue Growth to Exceed Over 20%, Analyst Predicts on the Back of AI-Powered Expansion

By Lekha Gupta
June 14, 12:51 PM
Needham & Co analyst Mike Cikos initiated coverage of ServiceNow Inc (NYSE: NOW) at a Buy rating with 

NOW

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • M&A
  • News

Illumina’s Grail Acquisition Gains Support from GOP Lawmakers and Advocacy Groups Despite FTC Resistance

By Vandana Singh
June 14, 12:15 PM
Republican lawmakers, state attorneys general, and several advocacy groups have expressed their support for Illumina Inc's (NASDAQ: ILMN) acquisition of Grail Inc, even as the Federal Trade Commission (FTC) continues challenging the deal. 

ILMN

Posts pagination

Previous 1 … 290 291 292 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service